RCS - MicroSalt PLC - Significant Expansion of Global Patent Portfolio

MicroSaltAnnouncement

04/10/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241004:nRSD9105Ga&default-theme=true

RNS Number : 9105G  MicroSalt PLC  04 October 2024

 

 

 

This is a Reach announcement and the information contained is not considered
to be material or to have a significant impact on management's expectations of
the Company's performance. Reach is an investor communication service aimed at
assisting listed and unlisted (including AIM quoted) companies to distribute
non-regulatory news releases into the public domain. Information required to
be notified under the AIM Rules for Companies, Market Abuse Regulation or
other regulation would be disseminated as an RNS regulatory announcement and
not on Reach.

 

 

4 October 2024

 

MicroSalt plc

("MicroSalt®" or the "Company")

Microsalt Announces Significant Expansion of Global Patent Portfolio

 

MicroSalt plc (AIM: SALT), a leading provider of full-flavour, natural salt
with approximately 50% less sodium, is pleased to announce multiple
developments in its patent portfolio worldwide.

 

The Company received a Certificate of Invention Patent in China for its patent
application entitled "Improved Low Sodium Salt Compositions," now issued as
Chinese Patent No. CN114206133.

 

In addition, on September 4, 2024, the Company received a Notice of Allowance
in Mexico for its Mexican Patent Application No. MX2022001611, entitled
"Improved Low Sodium Salt Composition." The Company anticipates a Mexican
Patent to issue after payment of final issuance and initial annuity fees.

 

On August 19, 2024, the Australian Patent Office accepted the Company's
Australian Patent Application No. AU2020326597, entitled "Improved Low Sodium
Salt Composition," initiating a three-month opposition period. If the accepted
application is not opposed, the Company anticipates an Australian patent to
issue after the end of the three-month opposition period.

 

The Chinese Patent, allowed Mexican Patent Application, and accepted
Australian patent application all claim priority to United States patent
applications that issued as United States Patent No. 11,992,034, entitled "Low
Sodium Salt Composition," and all are directed to a low sodium salt
composition comprising salt adhered to a carrier particle produced according
to a claimed process.

 

The Company has additional pending patent applications directed to its a low
sodium salt composition comprising salt adhered to a carrier particle produced
according to a claimed process in Canada, Hong Kong, Chile, Japan, Europe,
Brazil, India, and Russia.

 

Rick Guiney, CEO of MicroSalt commented: "We are very pleased to witness the
expansion of our intellectual property portfolio into some of the largest
sodium markets in the world. We have made commercial inroads with customers in
Asia, Europe and Australia and we see this development as very timely".

About MicroSalt plc

MicroSalt® is dedicated to innovating food technology solutions that enable
people to live longer, healthier, and happier lives. Its patented low-sodium
salt delivers natural salt with approximately 50% less sodium and may be used
by both consumers and food manufacturers to decrease the amount of sodium in
their food. SaltMe! chips are produced using MicroSalt®, a patented
innovative salt technology which is 100% natural, non-GMO, gluten free, and
Kosher certified, that does not contain any potassium chloride. To learn more
about MicroSalt Inc. and MicroSalt® products, please visit
https://microsalt.co (https://microsalt.co) , follow on X @microSaltPLC or
contact:

 

 MicroSalt plc                                                     Via Flagstaff
 Rick Guiney, CEO

 Flagstaff PR (Financial IR/FPR)                                   +44 (0)20 7129 1474
 Tim Thompson / Alison Allfrey / Anna Probert

 microsalt@flagstaffcomms.com

 

 

Notes to Editors

 

MicroSalt® produces a patented full-flavour, low-sodium salt for food
manufacturers and consumers.

 

MicroSalt is a major potential disruptor in the food market, thanks to its
micron sized particles which deliver the same sense of saltiness to a wide
range of foods but with approximately 50% less sodium. Excess sodium
consumption is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier alternatives to
traditional salt. The WHO has set a target for reducing global sodium intake
by 30% by 2025, which it estimates will save 7 million lives by 2030.

 

Each year, cardiovascular disease costs the UK £19 billion - if the average
salt intake was reduced by one gram per day, it has been estimated that 4,147
lives and £288 million would be saved each year in the UK. As a nation, the
UK consumes 183 million kilograms of salt each year, and 70% of the typical
person's sodium intake is hidden in processed foods.

 

Operational since 2018, MicroSalt uses a patent-protected technology which
helps create high barriers to entry within the reduced-sodium salt market.

 

The Directors believe that MicroSalt is well positioned to capture growth in
the low sodium market, which is expected to grow exponentially, and that there
is also scope to enter the larger salt market.

 

ENDS

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUOSARSOURRUA